NASDAQ: IMUXImmunic Inc Stock Ownership - Who owns Immunic?
Insider buying vs selling
Have Immunic Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Duane Nash | Executive Chairman | 2025-06-13 | 20,000 | $0.84 | $16.70kBuy |
| Joerg Neermann | Director | 2025-06-05 | 30,000 | $0.76 | $22.80kBuy |
| Jason Tardio | President and COO | 2025-06-05 | 12,512 | $0.79 | $9.88kBuy |
| Jason Tardio | President and COO | 2025-06-05 | 12,512 | $0.79 | $9.88kBuy |
| Joerg Neermann | Director | 2025-06-04 | 70,000 | $0.77 | $53.90kBuy |
| Daniel Vitt | CEO and Director | 2025-06-04 | 15,000 | $0.77 | $11.55kBuy |
| Daniel Vitt | CEO and Director | 2025-06-04 | 15,000 | $0.77 | $11.55kBuy |
| Glenn Whaley | Chief Financial Officer | 2025-06-03 | 45,000 | $0.71 | $32.09kBuy |
| Richard Alan Rudick | Director | 2025-06-03 | 143,075 | $0.70 | $100.01kBuy |
| Glenn Whaley | Chief Financial Officer | 2025-05-30 | 25,000 | $0.56 | $14.00kBuy |
IMUX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IMUX insiders and whales buy or sell their stock.
IMUX Shareholders
What type of owners hold Immunic Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Aberdeen Group PLC | 6.32% | 8,243,941 | $9.48M | Institution |
| Bvf Inc | 5.87% | 7,652,972 | $8.80M | Institution |
| Muneer A. Satter | 5.47% | 7,132,277 | $8.20M | Insider |
| Vanguard Group Inc | 3.85% | 5,020,337 | $5.77M | Institution |
| Avidity Partners Management LP | 3.60% | 4,699,411 | $5.40M | Institution |
| Nantahala Capital Management LLC | 3.36% | 4,378,406 | $5.04M | Institution |
| Laurion Capital Management LP | 2.98% | 3,882,162 | $4.46M | Institution |
| Millennium Management LLC | 2.62% | 3,419,299 | $3.93M | Institution |
| Focus Partners Wealth | 2.01% | 2,622,462 | $3.02M | Institution |
| V. Cooperatieve Ua Lsp | 1.66% | 2,162,782 | $2.49M | Insider |
IMUX vs Biotech Stocks
Immunic Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.